| Name |
Lacydyna 4 mg filmom obložene tablete |
| Former Name |
Lacidipin DOUBLE-E PHARMA 4 mg filmom obložene tablete |
| Marketing Authorisation Number |
HR-H-775859065 |
| Active Substance |
lacidipin |
| Composition |
svaka filmom obložena tableta sadržava 4 mg lacidipina |
| Pharmaceutical Form |
filmom obložena tableta |
| Manufacturer |
Holsten Pharma GmbH, Frankfurt am Main , Njemačka |
| Marketing Authorisation Holder |
Double-E Pharma Ltd., 5th Floor, Block A, The Atrium, Blackthorn Road, Sandyford Business Park , Dublin 18, Co. Dublin , Irska |
| Marketing Authorisation Date |
11.03.2020 |
| MA Period of Validity |
unlimited |
| Classification Number |
UP/I-530-09/19-02/136 |
| Registration Number |
381-12-01/70-20-03 |
| Prescription |
Medicinal product subject to medical prescription |
| Type of prescription |
Medicinal product on medical prescription for renewable delivery
|
| Distribution |
Supply through pharmacies (community) |
| Advertising to general public |
not allowed |
| ATC Code |
C08CA09 |
| Marketing status |
Not marketed |
| SmPC |
download |
| PL |
download |
| Public Assessment Report |
download
|
